Study assessing suboptimal response after covid vaccination in liver transplant recipients and those with chronic liver diseases
Latest Information Update: 13 Jan 2022
At a glance
- Drugs Ad26.COV2 S (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 13 Jan 2022 New trial record
- 15 Nov 2021 Results presented at The Liver Meeting 2021: 72nd Annual Meeting of the American Association for the Study of Liver Diseases